Skip to main content
Premium Trial:

Request an Annual Quote

Evident Technologies Biotin EviFluors, De Novo Pharmaceuticals and Peakdale Molecular s Peakexplorer, and TSG Partners Market Research Reports


Evident Technologies announced last week that it has begun commercial production of Biotin EviFluors, its first biotinylated quantum dot fluorophores.

EviFluor offers advantages over traditional fluorophores, including brighter emission and greater stability, for applications such as cell biology, drug discovery, and cancer research, the company said. The product is available in wavelengths from blue to infrared.

De Novo Pharmaceuticals said last week that it has launched a new range of Peakexplorer screening compound libraries as a result of the company’s collaboration with Peakdale Molecular.

The libraries were designed using De Novo’s SkelGen computational drug-design platform. The first library is focused on G-protein coupled receptors and contains more than 1,000 proprietary drug-like compounds, the company said.

TSG Partners has announced the availability of market research reports on high-content screening, cell-based assays, and RNAi. Free, condensed samples of the reports can be downloaded at

TSG Partners is a specialty corporate advisory firm focused solely on emerging and volatile sectors in the life sciences, drug discovery and development, diagnostics, environmental controls and water treatment sectors.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.